These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 6365321

  • 1. [Intermittent treatment of pulmonary tuberculosis--controlled clinical trials in Czechoslovakia].
    Víznerová A.
    Cas Lek Cesk; 1984 Feb 10; 123(6):165-9. PubMed ID: 6365321
    [No Abstract] [Full Text] [Related]

  • 2. [Intermittent chemotherapy of middle-aged and elderly patients with pulmonary tuberculosis].
    Iashchenko BP.
    Probl Tuberk; 1983 Mar 10; (3):29-33. PubMed ID: 6344067
    [No Abstract] [Full Text] [Related]

  • 3. [Controlled clinical trial of a 3-month regimen and 2 5-month regimens in the treatment of pulmonary tuberculosis. 2d study of the short-term treatment administered in Madras].
    Tripathy SP.
    Bull Int Union Tuberc; 1983 Jun 10; 58(2):97-101. PubMed ID: 6360263
    [No Abstract] [Full Text] [Related]

  • 4. [Cooperative international studies, carried out in Czechoslovakia, on the length of hospital stay, intermittent continuation regimens, and total length of treatment].
    Polansky F, Vodrazkova A, Viznerova A.
    Bull Int Union Tuberc; 1974 Jun 10; 49(1):435-41. PubMed ID: 4619564
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical experiences with morphazinamide administered in slow venous perfusion in the treatment of pulmonary tuberculosis].
    Censi G, Orlandini GC.
    Minerva Med; 1965 Sep 05; 56(71):2881-92. PubMed ID: 5322269
    [No Abstract] [Full Text] [Related]

  • 6. [Controlled chemotherapy methods in fibrous-cavernous pulmonary tuberculosis with severe concomitant diseases].
    Utkin VV, Poleshchuk AK, Shmeleva VI.
    Probl Tuberk; 1978 Apr 05; (4):17-23. PubMed ID: 349548
    [No Abstract] [Full Text] [Related]

  • 7. [Unmonitored ambulatory short-term therapy of pulmonary tuberculosis].
    Reinert M, Chritmann K, Kropp R, Lutgen W, Otte W, Steurich F.
    Prax Klin Pneumol; 1983 Oct 05; 37 Suppl 1():458-9. PubMed ID: 6359125
    [No Abstract] [Full Text] [Related]

  • 8. [A controlled trial of 6-month and 12-month regimens after negative conversion of sputum in the original treatment of pulmonary tuberculosis. Report of the 21st series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Kekkaku; 1984 Feb 05; 59(2):81-9. PubMed ID: 6379258
    [No Abstract] [Full Text] [Related]

  • 9. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
    Pilipchuk NS.
    Vrach Delo; 1981 Jan 05; (1):47-9. PubMed ID: 7010782
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical observations on morphazinamide administered by intravenous perfusion in therapy of pulmonary tuberculosis].
    Lucchesi M, Pallotta G, Fantoli U.
    Minerva Med; 1965 Sep 05; 56(71):2914-8. PubMed ID: 5322276
    [No Abstract] [Full Text] [Related]

  • 11. [Morphazinamide by venous perfusion in therapy of pulmonary tuberculosis].
    Leoncini G, Bolondi O, Costi TF.
    Minerva Med; 1965 Sep 05; 56(71):2910-3. PubMed ID: 5322275
    [No Abstract] [Full Text] [Related]

  • 12. [Results of controlled therapeutic trials. II. Intermittent regimens. Conclusion].
    Sunahara S.
    Bull Int Union Tuberc; 1974 Sep 05; 49(1):456-7. PubMed ID: 4619568
    [No Abstract] [Full Text] [Related]

  • 13. [New aspects of short-term chemotherapy of tuberculosis].
    Zierski M, Snider DE.
    Prax Klin Pneumol; 1983 Oct 05; 37 Suppl 1():473-6. PubMed ID: 6359126
    [No Abstract] [Full Text] [Related]

  • 14. [Effects of morphazinamide in monomedicamentous therapy per os and intravenously in pulmonary tuberculosis].
    Sorrentino F, Calagna L.
    Minerva Med; 1965 Sep 05; 56(71):2938-42. PubMed ID: 5322280
    [No Abstract] [Full Text] [Related]

  • 15. [Intermittent chemotherapy of pulmonary tuberculosis. With particular emphasis on the contribution of the WHO Cooperative Center for Tuberculosis Chemotherapy in Prague].
    Fox W.
    Cas Lek Cesk; 1984 Feb 10; 123(6):153-7. PubMed ID: 6365320
    [No Abstract] [Full Text] [Related]

  • 16. [On therapeutic effects of morphazinamide, used alone and in association, in recent and chronic pulmonary tuberculosis].
    Pasargiklian M.
    Minerva Med; 1965 Sep 05; 56(71):2855-62. PubMed ID: 5322267
    [No Abstract] [Full Text] [Related]

  • 17. [Complex hospital treatment of pulmonary tuberculosis].
    Bondarev IM, Batmanov NIa, Shesterina MV, Gavrilenko VS, Tarasova EF.
    Sov Med; 1980 Sep 05; (6):79-82. PubMed ID: 6998023
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical findings on curative action of morphazinamide, administered intravenously, to patients with pulmonary tuberculosis].
    Cacciavillani B.
    Minerva Med; 1965 Sep 05; 56(71):2878-81. PubMed ID: 5322268
    [No Abstract] [Full Text] [Related]

  • 19. [Results of therapy with morphazinamide administered orally in association with other antitubercular drugs].
    Curiale G, Tocco G.
    Minerva Med; 1965 Sep 05; 56(71):2943-8. PubMed ID: 5322281
    [No Abstract] [Full Text] [Related]

  • 20. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan 05; 55(1):7-13. PubMed ID: 6988627
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.